Ken Fisher’s Amedisys AMED Stock Holding History

Ken Fisher’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-965	Closed	-$228K	–	924
2020 Q3	$228K	Buy	+965	New	+$219K	﹤0.01%	791

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ken Fisher's AMED Position: Q4 2020 in Review

Ken Fisher sold out of Amedisys (AMED) in Q4 2020, closing a stake of 965 shares — an estimated $228K sold.

Ken Fisher first reported a position in AMED in Q3 2020 and held it in 1 quarter. The position peaked at $228K in Q3 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q4 2020.

Ken Fisher reported no remaining Amedisys position as of Q4 2020 after selling out during the quarter.
Ken Fisher sold 965 Amedisys shares in Q4 2020, an estimated $228K.
Ken Fisher first reported a position in Amedisys in Q3 2020 and held it in 1 quarter.
Ken Fisher's Amedisys position peaked at $228K in Q3 2020.
397 funds tracked by Wall St. Rank held Amedisys as of Q4 2020.

Based on Fisher Asset Management's 13F filing for Q4 2020, filed 29 Jan 2021.